ZDA
CELL

Zweig-DiMenna Associates’s PhenomeX Inc. Common Stock CELL Stock Holding History

Zweig-DiMenna Associates’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-82,221
Closed -$220K – 130
2022
Q4 		$220K Hold
82,221
– – 0.03% 107
2022
Q3 		$235K Hold
82,221
– – 0.05% 85
2022
Q2 		$409K Hold
82,221
– – 0.08% 83
2022
Q1 		$585K Buy
+82,221
New +$680K 0.08% 94

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Zweig-DiMenna Associates's CELL Position: Q1 2023 in Review

Zweig-DiMenna Associates sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 82,221 shares — an estimated $220K sold.

Zweig-DiMenna Associates first reported a position in CELL in Q1 2022 and held it in 4 quarters. The position peaked at $585K in Q1 2022. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • Zweig-DiMenna Associates reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 82,221 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $220K.
  • Zweig-DiMenna Associates first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Zweig-DiMenna Associates's PhenomeX Inc. Common Stock position peaked at $585K in Q1 2022.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2023, filed 28 Apr 2023.